Objectives
Left ventricular (LV) assist device (LVAD) support reduces pathological loading. However, load-induced adaptive responses may be suppressed. Pathological loading dysregulates cardiac G protein-coupled receptor (GPCR) signaling. Signaling through G proteins is deleterious, whereas beta (β)-arrestin-mediated signaling is cardioprotective. We examined the effects of pathological LV loading/LV dysfunction and treatment via LVAD, on β-arrestin-mediated signaling, and genetic networks downstream of load.
Methods
An ovine myocardial infarction (MI) model was employed. Sheep underwent either sham thoracotomy (n=3), mid-left anterior descending coronary artery ligation to produce MI (n=3), or MI with placement of a small platform catheter-based LVAD (n=3). LVAD support was continued for 2 weeks. Animals were maintained for a total of 12 weeks. Myocardial specimens were harvested and analyzed.
Results
MI induced β-arrestin activation. Increased interactions between the EGF receptor and β-arrestins were observed. LVAD support inhibited these responses to MI (p < 0.05). LVAD support inhibited activation of cardioprotective signaling effectors Akt (p < 0.05), and to a lesser extent, ERK1/2 (p = NS). However, MI resulted in regional activation of load-induced GPCR signaling via G proteins, as assessed by induction of atrial natriuretic peptide (ANP) mRNA expression in the MI-adjacent zone relative to the MI-remote zone (p < 0.05). MI-adjacent zone ANP expression was renormalized with LVAD support.
Conclusions
LVAD support inhibited cardioprotective β-arrestin-mediated signaling. However, net benefits of normalization of load-induced GPCR signaling were observed in the MI-adjacent zone. These findings may have implications for the optimal extent and duration of unloading, and adjunctive medical therapies.